FDA Approves Obesity Pill From Eli Lilly

Date:

US NewsThe pill can be taken without food or water, its manufacturer says.An Eli Lilly and Company pharmaceutical manufacturing plant at 50 Imclone Drive in Branchburg, N. J., on March 5, 2021. Mike Segar/ReutersZachary StieberSenior Reporter4/1/2026|Updated: 4/1/20260:00U.S. regulators on April 1 approved an obesity pill called Foundayo from Eli Lilly, adding a second option for consumers who want to take weight loss drugs but desire to avoid injections.Foundayo is a glucagon-like peptide-1 (GLP-1) medication meant to be taken once a day.

spot_imgspot_imgspot_img

Share post:

More like this
Related

Reality Index vs Official Inflation Numbers

CommentaryThe recent Consumer Price Index (CPI) posted what seemed...

How to Use TIPS in Your Portfolio

Treasury Inflation-Protected Securities (TIPS) were introduced in 1997 to...

Rubio Tells ASEAN Partners US Willing to Negotiate With an Iran That Keeps Commitments

U.S. Secretary of State Marco Rubio told America’s ASEAN...

Trump Says US Will Hit Irans Power Plants, Bridges If Tehran Attacks Ships

President Donald Trump on Wednesday warned Iran’s regime that...